Skip to main content
Clinical Trials/CTRI/2025/02/080727
CTRI/2025/02/080727
Not yet recruiting
Not Applicable

A Comparative clinical study on the usefullness of Individualized homoeopathic medicine v/s Teucrium Marum Verum in the management of Nasal Polyp

Pooja Bharti1 site in 1 country60 target enrollmentStarted: February 20, 2025Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Pooja Bharti
Enrollment
60
Locations
1
Primary Endpoint
To compare the changes in scoring in before and after treatment using SNOT 20 in patients with nasal polyp at baseline and after 6 months of treatment to compare the effectiveness of Teucrium Marum Verum and Individualized Homoeopathic medicines

Overview

Brief Summary

Nasal polyps are a manifestation of chronic rhinosinusitis with nasal polyps (CRSwNP), which is a chronic inflammatory condition affecting the sinus and nasal cavities. These polyps are often the result of long-term inflammation, frequently linked to conditions like chronic rhinitis, asthma, and allergies. They are common in adults, particularly those aged 40-60, and more prevalent in males. Symptoms include nasal congestion, loss of smell, chronic runny nose, and sometimes facial pain or headaches.

The exact cause of nasal polyps remains unknown, but it is linked to chronic inflammation. The condition can significantly affect a person’s quality of life and impose substantial financial costs due to medical expenses and lost productivity. Treatment typically involves a combination of medical management (such as antihistamines and steroids) and surgery for severe cases.

Homeopathic treatments, including Teucrium marum verum, have shown some promise in treating nasal polyps, although further research is needed to assess their efficacy fully. The study outlined aims to evaluate the comparative efficacy of individualized homeopathic treatment versus Teucrium marum verum in managing nasal polyps, using tools like the SNOT-20 questionnaire to measure symptom severity and patient well-being.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
16.00 Year(s) to 45.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • 1.Both male and female will be included.
  • 2.Participants diagnosed with nasal polyp 3.Age group of 16 -45years suffering from nasal polyp will be included 4.Participants who will be ready to give consent and assent.

Exclusion Criteria

  • 1.Participants on other medication .
  • 2.Participants with other upper respiratory tract infections (laryngitis, pharyngitis, diphtheria, etc.) 3.Pregnant and lactating female.
  • 4.Uncontrolled systemic or psychiatric illness .
  • 5.Participants with other respiratory infections (chronic bronchitis, bronchial Asthma, cystic fibrosis).

Outcomes

Primary Outcomes

To compare the changes in scoring in before and after treatment using SNOT 20 in patients with nasal polyp at baseline and after 6 months of treatment to compare the effectiveness of Teucrium Marum Verum and Individualized Homoeopathic medicines

Time Frame: 12 weeks, 24 weeks

Secondary Outcomes

  • To compare the changes in size of nasal polyp using Xray-PNS at baseline and every 3 month of treatment(12weeks, 24 weeks)

Investigators

Sponsor
Pooja Bharti
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Pooja Bharti

State National Homoeopathic Medical College and Hospital, Viraj khand -1, Gomti Nagar, Lucknow

Study Sites (1)

Loading locations...

Similar Trials